Comparative Effectiveness of Rosuvastatin Versus Atorvastatin in Acute Ischemic Stroke Treatment

瑞舒伐他汀 医学 阿托伐他汀 冲程(发动机) 危险系数 内科学 心肌梗塞 心脏病学 比例危险模型 置信区间 机械工程 工程类
作者
Joon‐Tae Kim,Ji Sung Lee,Hyunsoo Kim,Beom Joon Kim,Jihoon Kang,Keon‐Joo Lee,Jong‐Moo Park,Kyusik Kang,Soo Joo Lee,Jae Guk Kim,Jae‐Kwan Cha,Dae‐Hyun Kim,Tai Hwan Park,Kyung Bok Lee,Jun Lee,Keun‐Sik Hong,Yong‐Jin Cho,Hong‐Kyun Park,Byung‐Chul Lee,Kyung‐Ho Yu
出处
期刊:Journal of the American Heart Association [Wiley]
卷期号:14 (3): e038080-e038080 被引量:9
标识
DOI:10.1161/jaha.124.038080
摘要

Background Research specifically addressing the efficacy of rosuvastatin versus atorvastatin in patients with ischemic stroke is insufficient. Using a large stroke registry, we investigated whether 2 commonly used statins, rosuvastatin and atorvastatin, differ in their effectiveness in reducing the risk of vascular events in patients with acute ischemic stroke. Methods We analyzed data from a nationwide stroke registry in South Korea between January 2011 and April 2022. Patients with acute ischemic stroke within 7 days of onset who were prescribed either atorvastatin or rosuvastatin at discharge were included. The primary outcome was a composite of recurrent stroke (either hemorrhagic or ischemic), myocardial infarction, and all‐cause mortality within 1 year. Results A total of 43 512 patients (age, 69.2±12.5 years; male, 59.8%) were analyzed in this study. Atorvastatin was used in 84.8% (n=36 903), and rosuvastatin was used in 15.2% (n=6609). The 1‐year cumulative event rate of the composite of recurrent stroke, myocardial infarction, and all‐cause mortality was significantly lower in the rosuvastatin group than in the atorvastatin group (9.7% [95% CI, 9.0–10.5] versus 10.7% [95% CI, 10.4–11.0]; P =0.049). Cox proportional hazards analysis revealed that rosuvastatin, compared with atorvastatin, was significantly associated with less risk of 1‐year composite of recurrent stroke, myocardial infarction, and all‐cause mortality, with an absolute risk reduction of 1% [95% CI, −1.8 to −0.2] and a relative risk reduction of 11% (hazard ratio, 0.89 [95% CI, 0.82–0.97]). However, there were discrepancies in the statistical significance of the results between the propensity score matching and stabilized inverse probability of treatment weighting analysis. Conclusions The results of this analysis of a large cohort of patients with ischemic stroke suggested that, compared with atorvastatin, rosuvastatin was significantly associated with a reduced risk of a 1‐year composite of recurrent stroke, myocardial infarction, and all‐cause mortality in patients with acute ischemic stroke. However, in real clinical practice, rosuvastatin is used less than one‐fifth as frequently as atorvastatin in patients with acute ischemic stroke. This study serves as a hypothesis‐generating function.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Didi完成签到,获得积分20
刚刚
1秒前
SMQ完成签到 ,获得积分10
2秒前
科研通AI6.2的应助被西瓜宝宝采纳,获得10
2秒前
炙热千柳完成签到,获得积分10
3秒前
科研通AI6.3的应助被tomorrow采纳,获得10
3秒前
3秒前
香蕉觅云的应助被俄克赛普特采纳,获得30
3秒前
Jasper的应助被JJ采纳,获得10
4秒前
魔幻的寒风完成签到,获得积分10
4秒前
科研人发布了新的文献求助10
5秒前
5秒前
6秒前
香蕉觅云的应助被徐XU采纳,获得10
6秒前
6秒前
7秒前
hh完成签到,获得积分10
7秒前
luoshiyi发布了新的文献求助10
7秒前
思源的应助被霁月采纳,获得10
7秒前
7秒前
8秒前
好天气完成签到,获得积分10
8秒前
8秒前
Hello的应助被言默采纳,获得10
9秒前
英吉利25发布了新的文献求助10
9秒前
小许小许锦鲤附体完成签到,获得积分10
9秒前
ZD123完成签到,获得积分10
10秒前
JamesPei的应助被TBLS采纳,获得10
10秒前
10秒前
11秒前
小熊维尼发布了新的文献求助10
12秒前
lucky发布了新的文献求助10
12秒前
洛枝发布了新的文献求助10
12秒前
李健的小迷弟的应助被Seclly采纳,获得10
12秒前
畅快珩完成签到,获得积分10
13秒前
Syanx_8发布了新的文献求助10
13秒前
14秒前
14秒前
英吉利25发布了新的文献求助10
14秒前
龙虾发票完成签到,获得积分0
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186480
求助须知:如何正确求助?哪些是违规求助? 9574861
关于积分的说明 21838499
捐赠科研通 7784154
什么是DOI,文献DOI怎么找? 3434775
关于科研通互助平台的介绍 2559164
邀请新用户注册赠送积分活动 2481565